Tag: U.K.
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.
-
Knowledge Bank Tapped for Precision Cancer Treatments
An international research team devised techniques for analyzing accumulated clinical trial data to help determine precise treatment strategies for people with cancer.
-
RNA-Nanoparticle Spray Protects Against Plant Viruses
Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses.
-
Neurology Drug Signals Shown to Help Tooth Repair
Chemical signals from a drug designed to treat Alzheimer’s disease and other neurological disorders were shown in tests with mice to stimulate stem cells that repair teeth.
-
Trial Testing Stem-Cell Implant for Cartilage Repair
An early clinical trial testing implants of a person’s stem cells to repair damaged knee cartilage in younger adults returned largely favorable results.
-
Biotech to Earn Up to $1 Billion from Synthetic Peptides
A biotechnology enterprise designing synthetic peptides to treat a range of diseases could gain up to $1 billion or more in a licensing deal with the pharmaceutical company AstraZeneca.
-
Algae Feed Proposed to Enrich Farm Salmon Fatty Acids
A developer of feeds for farmed salmon says its algae-based feed supplements could arrest the sharp decline in omega-3 fatty acids discovered in a recent study.
-
Seedless Fruit Varieties Seen As Food Security Boost
A review of studies evaluating techniques for producing seedless fruit concludes these techniques can contribute to higher yields that help ensure the security of food supplies.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.